Patents Assigned to CONCERT PHARMCEUTICALS, INC.
  • INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN
    Publication number: 20080242711
    Abstract: The invention relates to novel oxazolidinones their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering cholesterol ester transfer protein inhibitors.
    Type: Application
    Filed: March 14, 2008
    Publication date: October 2, 2008
    Applicant: CONCERT PHARMCEUTICALS, INC.
    Inventor: Roger Tung